Can a better understanding of frailty improve the quality of life of patients with fibrotic interstitial lung diseases? Source: Eur Respir J, 55 (1) 1902255; 10.1183/13993003.02255-2019 Year: 2020
COPD as a lung disease with heterogeneous systemic inflammatory consequences: clinical impact Source: Research Seminar 2011 - Physical activity, nutritional status and systemic inflammation in COPD Year: 2011
Quality of life and health status in interstitial lung diseases Source: Annual Congress 2008 - COPD and miscellaneous Year: 2008
Frequency and impact of interstitial lung disease on clinical state and mortality in systemic scleroderma Source: Annual Congress 2012 - Diffuse parenchymal lung disease III Year: 2012
Patient-reported quality of life in fibrotic interstitial lung disease: novel assessments of self-management ability and affect Source: ERJ Open Res, 7 (1) 00011-2021; 10.1183/23120541.00011-2021 Year: 2021
The impact of aging on COPD, cardiovascular comorbidities and systemic inflammation Source: International Congress 2019 – Cardiovascular comorbidities in COPD Year: 2019
Health status and psychological assessments Source: Annual Congress 2007 - PG6 - COPD: comprehensive clinical assessment and pharmacological and nonpharmacological therapy Year: 2007
Neuropsychological status and health related quality of life in patients with chronic obstructive pulmonary disease Source: Annual Congress 2007 - Clinical aspects of COPD II Year: 2007
Predictors of quality of life in patients with interstitial lung disease Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease Year: 2009
Patients' perceptions and patient-reported outcomes in progressive-fibrosing interstitial lung diseases Source: Eur Respir Rev, 27 (150) 180075; 10.1183/16000617.0075-2018 Year: 2018
Assessing cardiocirculatory compensation capacity in COPD: impact of disease severity. Source: Virtual Congress 2020 – Respiratory diseases, hypoxia and cardiovascular function Year: 2020
Increased self-management capacity leads to improved health outcomes for chronic lung disease patients Source: Eur Respir J 2005; 26: Suppl. 49, 72s Year: 2005
Community pulmonary rehabilitation for COPD: physical, psychological and quality of life improvements are independent of age and disease severity Source: Eur Respir J 2007; 30: Suppl. 51, 93s Year: 2007
Impact of social distancing during the COVID-19 pandemic on clinical outcomes of patients with interstitial lung disease Source: Virtual Congress 2021 – Symptoms across respiratory diseases and impact of COVID-19 Year: 2021
Health-related quality of life and health status among patients with sarcoidosis, chronic obstructive pulmonary disease and interstitial lung disease Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management Year: 2018
Psychological predictors of health-related quality of life of interstitial lung disease patients. Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment Year: 2019
Exercise pulmonary haemodynamic response predicts outcomes in fibrotic lung disease Source: Eur Respir J, 52 (3) 1801015; 10.1183/13993003.01015-2018 Year: 2018
Impact of preventing exacerbations on deterioration of health status in COPD Source: Eur Respir J 2004; 23: 698-702 Year: 2004
Physical activity and clinical outcomes in patients with interstitial lung disease: how large is the impairment? – Preliminary results Source: International Congress 2018 – Chronic respiratory disease : determinants of physical activity in patients Year: 2018